Vivos Therapeutics (VVOS) Gross Margin (2020 - 2026)
Vivos Therapeutics (VVOS) reported Gross Margin of 59.5% for Q1 2026, up 947.0% year-over-year from 5.68% in Q1 2025, and down 23.85% on a QoQ basis from 78.14% in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Gross Margin data on file, last reported at 59.5% in Q1 2026.
- Quarterly Gross Margin rose 947.0% year-over-year to 59.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61.8% (up 308.0% YoY) and the FY2025 annual result came in at 60.44%, up 43.0% from the prior year.
- Gross Margin slipped to 59.5% in Q1 2026 per VVOS's latest filing, from 78.14% in the prior quarter.
- Across five years, Gross Margin topped out at 78.14% in Q4 2025 and bottomed at 50.03% in Q1 2025.
- The 5-year median for Gross Margin is 60.35% (2022), against an average of 60.64%.
- The widest annual swing landed in 2022, when Gross Margin slumped 1873 bps; it then jumped 2143 bps in 2025.
- Tracing VVOS's Gross Margin over 5 years: stood at 60.35% in 2022, then rose by 7 bps to 64.32% in 2023, then retreated by 12 bps to 56.71% in 2024, then jumped by 38 bps to 78.14% in 2025, then dropped by 24 bps to 59.5% in 2026.
- Per Business Quant, the three latest VVOS Gross Margin figures stand at 59.5% (Q1 2026), 78.14% (Q4 2025), and 58.04% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 59.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.50% |
| Dec 31, 2025 | 78.14% |
| Sep 30, 2025 | 58.04% |
| Jun 30, 2025 | 55.24% |
| Mar 31, 2025 | 50.03% |
| Dec 31, 2024 | 56.71% |
| Sep 30, 2024 | 60.47% |
| Jun 30, 2024 | 65.39% |
| Mar 31, 2024 | 56.65% |
| Dec 31, 2023 | 64.32% |
| Sep 30, 2023 | 52.92% |
| Jun 30, 2023 | 61.80% |
| Mar 31, 2023 | 60.59% |
| Dec 31, 2022 | 60.35% |
| Sep 30, 2022 | 58.78% |
| Jun 30, 2022 | 61.85% |
| Mar 31, 2022 | 70.01% |
| Dec 31, 2021 | 70.71% |
| Sep 30, 2021 | 70.02% |
| Jun 30, 2021 | 80.59% |
| Mar 31, 2021 | 78.02% |
| Dec 31, 2020 | 81.30% |
| Sep 30, 2020 | 78.45% |
| Jun 30, 2020 | 83.34% |
| Mar 31, 2020 | 75.58% |